Given the availability of safer technologies, the authors say broader implementation of enhanced radiation protection devices (ERPDs) is both an ethical responsibility and a necessary evolution of ALARA (“As Low As Reasonably Achievable”),...
Given the availability of safer technologies, the authors say broader implementation of enhanced radiation protection devices (ERPDs) is both an ethical responsibility and a necessary evolution of ALARA (“As Low As Reasonably Achievable”),...
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
CHULA VISTA, CA. — The Society of Cardiovascular Computed Tomography (SCCT) announced its best original science award winners of the 21st Annual Scientific Meeting (SCCT2026) in San Diego, Calif.
The SCCT Best Abstract Award – supported by...
CHULA VISTA, CA. — The Society of Cardiovascular Computed Tomography (SCCT) announced its best original science award winners of the 21st Annual Scientific Meeting (SCCT2026) in San Diego, Calif.
The SCCT Best Abstract Award – supported by...
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
SAN CLEMENTE, CA — Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported...
SAN CLEMENTE, CA — Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported...
“Healthcare is increasingly moving beyond the traditional hospital setting, and this acquisition positions us to lead that transformation,” said Eduardo Conrado, President and Chief Executive Officer of Ascension.
“Healthcare is increasingly moving beyond the traditional hospital setting, and this acquisition positions us to lead that transformation,” said Eduardo Conrado, President and Chief Executive Officer of Ascension.
The RED 72 SILVER LABEL devices are reperfusion catheters designed for acute ischemic stroke. Direct aspiration with RED 72 SILVER LABEL can provide a fast, frontline option for acute ischemic stroke. The COMPASS Trial has shown...
The RED 72 SILVER LABEL devices are reperfusion catheters designed for acute ischemic stroke. Direct aspiration with RED 72 SILVER LABEL can provide a fast, frontline option for acute ischemic stroke. The COMPASS Trial has shown...
This technique is expected to function as a simple, low-burden screening tool to help determine whether cardiac MRI is necessary in patients whose PR severity cannot be reliably assessed using echocardiography.
This technique is expected to function as a simple, low-burden screening tool to help determine whether cardiac MRI is necessary in patients whose PR severity cannot be reliably assessed using echocardiography.
